# ORAgene Dx

> Active: European Union and United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/oragene-dx-ogd-575>
- Manufacturer: [DNA Genotek Inc.](https://devicerts.com/manufacturers/dna-genotek-inc) (Canada)
- Device class: Class A (EU IVDR); Class II (US FDA)
- FDA product code: OYJ
- EMDN: A1101 SAMPLE COLLECTION NEUTRAL SWABS
- EMDN: W05019002 SALIVA COLLECTION DEVICES
- GMDN: Specimen stabilization reagent IVD (61935)

## Registrations and authorizations

- **EUDAMED** · CE/IVDR · European Union · Basic UDI-DI 0627595A0100EF · UDI-DI 00627595000224 · registered 2024-06-11 · status: Active
- **GUDID** · GUDID listing · United States · UDI-DI 00627595000224 · listed 2016-09-08 · status: Listed (GUDID: in commercial distribution)
- **GUDID** · FDA 510(k) · United States · K110701 · issued 2011-12-02 · status: Active · from GUDID

## Recalls

No recall on record.

## Identity

- Generic name: Specimen stabilization reagent IVD [FDA GUDID (AccessGUDID)]
- Device name: ORAgene (Swab-based DNA & Dx Collection Device) [EUDAMED]
- Model / reference: OGD-575 [EUDAMED, FDA GUDID (AccessGUDID)]

## Identifiers

- Primary DI / UDI-DI: 00627595000224 [EUDAMED, FDA GUDID (AccessGUDID)]
- Basic UDI-DI: 0627595A0100EF [EUDAMED]
- 510(k) Number: K110701 [FDA GUDID (AccessGUDID)]
- FDA product code: OYJ [FDA GUDID (AccessGUDID)]
- EMDN code: A1101 [EUDAMED]; W05019002 [EUDAMED]
- GMDN term: Specimen stabilization reagent IVD (61935) [FDA GUDID (AccessGUDID)]

## Classification

- Device class: Class A [EUDAMED]; Class II [FDA GUDID (AccessGUDID)]
- Regulation number: 862.1675 [FDA GUDID (AccessGUDID)]
- EU registration type: Standard device [EUDAMED]
- EU market of registration: Belgium [EUDAMED]
- GUDID distribution status: In Commercial Distribution [FDA GUDID (AccessGUDID)]

## Properties

- Single use: Yes [FDA GUDID (AccessGUDID)]
- IVD kit: Yes [EUDAMED]
- Prescription use: Yes [FDA GUDID (AccessGUDID)]
- Over-the-counter: Yes [FDA GUDID (AccessGUDID)]
- Lot / batch number: Yes [FDA GUDID (AccessGUDID)]
- Expiration date: Yes [FDA GUDID (AccessGUDID)]
- Supplied sterile: No [EUDAMED, FDA GUDID (AccessGUDID)]
- Sterilise before use: No [EUDAMED, FDA GUDID (AccessGUDID)]
- Implantable: No [FDA GUDID (AccessGUDID)]
- Contains latex: No [FDA GUDID (AccessGUDID)]
- Contains human tissues or cells: No [EUDAMED]
- Contains animal tissues or cells: No [EUDAMED]
- Contains substances of microbial origin: No [EUDAMED]
- Reagent: No [EUDAMED]
- Self-testing: No [EUDAMED]
- Near-patient testing: No [EUDAMED]
- Professional testing: No [EUDAMED]
- Companion diagnostics: No [EUDAMED]
- IVD instrument: No [EUDAMED]
- New device: No [EUDAMED]
- Convenience kit: No [FDA GUDID (AccessGUDID)]
- Combination product: No [FDA GUDID (AccessGUDID)]
- HCT/P: No [FDA GUDID (AccessGUDID)]
- Premarket exempt: No [FDA GUDID (AccessGUDID)]
- Serial number: No [FDA GUDID (AccessGUDID)]
- Manufacturing date: No [FDA GUDID (AccessGUDID)]

## Source and citation

- Cite as: ORAgene Dx, DNA Genotek Inc. deviCERTS medical device catalogue. https://devicerts.com/devices/oragene-dx-ogd-575 (data as of 2026-11-16).
- Data sources: [EUDAMED](https://ec.europa.eu/tools/eudamed), [FDA GUDID (AccessGUDID)](https://accessgudid.nlm.nih.gov/)
- Registry records last synced: 2026-10-22
- Statuses computed as of: 2026-11-16
- JSON: <https://devicerts.com/devices/oragene-dx-ogd-575.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/oragene-dx-ogd-575
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
